Limit search to available items
Book Cover
E-book
Author Kremer, Michael, 1964-

Title Strong medicine : creating incentives for pharmaceutical research on neglected diseases / Michael Kremer and Rachel Glennerster
Published Princeton, NJ : Princeton University Press, 2004

Copies

Description 1 online resource (xiv, 153 pages) : illustrations
Contents Cover ; Title ; Copyright ; Dedication ; CONTENTS ; Foreword ; Acknowledgments ; 1. INTRODUCTION ; 2. HEALTH IN LOW-INCOME COUNTRIES ; The Disease Environment in Low-Income Countries ; Weak Health-Care Infrastructure ; Malaria, Tuberculosis, and HIV/AIDS
The Impact of Cheap, Simple Technologies 3. THE PAUCITY OF PRIVATE R & D TARGETED TO THE NEEDS OF LOW-INCOME COUNTRIES ; The Extent of R & D Targeted to Low-Income Countries ; The Scientific Potential for New Vaccines ; 4. MARKET AND GOVERNMENT FAILURES
Why Target Foreign Assistance to Vaccine R & D? The Patent Tradeoff ; Low-Income Countries and Intellectual Property ; Social versus Private Return: Some Quantitative Estimates ; The Role of Public Purchases ; 5. THE ROLE OF PUSH PROGRAMS
Meningococcal Meningitis: An Example of a Successful Push Program A Cautionary Tale: The USAID Malaria Vaccine Program ; Incentives under Push Programs ; 6. THE POTENTIAL ROLE OF PULL PROGRAMS ; The Effect of Market Size on Innovation ; The Impact of Financial Incentive Programs
Examples of Pull Programs Stimulating Research Advantages and Limitations of Pull Programs ; 7. PULL PROGRAMS: A MENU ; Commitments to Finance Purchase of Products and Patents ; Patent Extensions on Other Pharmaceuticals as Compensation for Vaccine Development ; Best-Entry Tournaments
Summary "Vaccines offer the best hope for controlling diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices." "In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries."--Jacket
Bibliography Includes bibliographical references (pages 127-143) and index
Notes Print version record
Subject Pharmacy -- Research -- Economic aspects -- Developing countries
Drugs -- Research -- Economic aspects -- Developing countries
Vaccines -- Research -- Economic aspects -- Developing countries
Drugs.
Research.
Vaccines.
Developing Countries
Economics, Pharmaceutical
Pharmaceutical Preparations
Research Support
Research
Vaccines
research (function)
POLITICAL SCIENCE -- Public Policy -- Social Security.
POLITICAL SCIENCE -- Public Policy -- Social Services & Welfare.
BUSINESS & ECONOMICS -- Economics -- Theory.
Vaccines.
Research.
Gesundheitsförderung
Arzneimittelforschung
Forschungsförderung
Forschungsfinanzierung
Drugs.
Farmaceutische industrie.
Drugs -- Research -- Economic aspects.
Onderzoek.
Pharmacy -- Research -- Economic aspects.
Keuzes.
Developing countries.
Entwicklungsländer
Form Electronic book
Author Glennerster, Rachel
ISBN 9781400880140
1400880149